Navigation Links
Genomma Lab Internacional Announces Third Quarter 2009 Results
Date:10/26/2009

MEXICO CITY, Oct. 26 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), announced today its results for the quarter ended September 30, 2009. All figures included herein were prepared in accordance with Mexican GAAP; figures are stated in nominal Mexican pesos. Also, the following consolidated figures show the Company's Spanish operations reclassified as discontinued operations according to Mexican GAAP.

3Q09 Highlights (vs. 3Q08)

  • During the third quarter of 2009, the Company launched Primer Nivel Por Tu Salud generic pharmaceuticals brand; the launch included 167 medical prescription ("RX") and over the counter pharmaceuticals ("OTC") products.
  • Also, during the third quarter, Genomma Lab signed a strategic alliance agreement with Grupo Televisa S.A.B. de C.V. (NYSE: TV) to market and distribute OTC and personal care products in the U.S. and Puerto Rico.
  • Net Sales for the quarter reached Ps. 1,123.7 million, an increase of 57.9%
  • EBITDA(1) increased 43.6%, to Ps. 296.8 million. This represents a 26.4% margin during the period.
  • Earnings per Share(2) increased 37.5%, to Ps. 1.09.
  • International Net Sales rose 295.9%, to Ps. 187.8 million.
  • During the third quarter, Genomma Lab successfully launched four products under three existing brands (Base Brands(3) and Prior Year Launches(4)) as part of our line extension strategy.
  • The Company also launched six products under four New Brands(5), as part of its new product launch plan during the third quarter.

(1) EBITDA is calculated by adding pre-operative expenses, depreciation and amortization to the operating income.

(2) Earnings per share are for the last 12 months and were calculated using the weighted average of shares outst
'/>"/>

SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Alimera Sciences, Inc. (NASDAQ: ALIM ) ... development and commercialization of prescription ophthalmic pharmaceuticals, today announced ... year 2014 financial results after the market close on ... follow on the same day at 4:30 p.m. ET. ... by Dan Myers , President and Chief Executive ...
(Date:7/24/2014)...  Perrigo Company (NYSE: PRGO ; TASE) ... equivalent rating from the U.S. Food and Drug Administration ... for testosterone gel 1.0%. FDA concluded that Perrigo,s testosterone ... can be substituted with the full expectation that it ... as AndroGel 1% when used under the conditions specified ...
(Date:7/24/2014)... July 24, 2014 Talyst, a market leader ... National Association of State Veterans Homes (NASVH) Summer Conference ... goal of the NASVH is to ensure that each ... long term health care and respect which they have ... With the InSite® Remote Dispensing System, Talyst can help ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter 2014 Results 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2
... a rattler may be a minor challenge for Rooster Cogburn ... , but proper handling of poor Mattie,s snakebite was a ... unknowingly perpetuates Hollywood myth by doing precisely the opposite of ... when it comes to the need for speed in seeking ...
... -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: ... products in China, today announced that it plans to release ... on Thursday, March 3, 2011. The Company ... March 3, 2011 to discuss fiscal year 2010 results. Listeners ...
Cached Medicine Technology:Oscar-Nominated True Grit Gets Top Reviews for Acting but Mixed Reviews for Snakebite Treatment 2Oscar-Nominated True Grit Gets Top Reviews for Acting but Mixed Reviews for Snakebite Treatment 3China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011 2
(Date:7/24/2014)... Dr. Henry H. Ting, a nationally recognized ... appointed senior vice president and chief quality officer at ... role, he will oversee the hospital's clinical quality and ... quality initiatives and interprofessional teams at the local, regional ... Door-to-Balloon Alliance, a collaboration of more than 1,000 hospitals ...
(Date:7/24/2014)... [Brown University] The U.S. Preventive Services Task ... for people at high risk for cancer, but ... patients will have positive results on the screening ... testing. Many policymakers have expressed concern that this ... needlessly upset. A new study of National Lung ...
(Date:7/24/2014)... night, which shuts off nighttime production of the hormone ... widely used breast cancer drug, says a new study ... study, "Circadian and Melatonin Disruption by Exposure to Light ... Breast Cancer," published in the journal Cancer Research ... vital to the success of tamoxifen in treating breast ...
(Date:7/24/2014)... (PRWEB) July 25, 2014 Voted one ... of the global clients, BellasDress focuses on providing its ... useful fashion information. Recently, the company has announced its ... in the new range is created according to the ... big discounts, up to 68% off. , As a ...
(Date:7/24/2014)... 24, 2014 Vulnerable populations such ... households are disproportionately affected by food security, despite ... in the United States, according to a new ... of the Consolidated Appropriations Act, 2014 (P.L. 113-76), ... and Nutrition Service (FNS) to contract with a ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Informed consent: False positives not a worry in lung cancer study 2Health News:Informed consent: False positives not a worry in lung cancer study 3Health News:Total darkness at night is key to success of breast cancer therapy -- Tulane study 2Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3
... ... No Tobacco Day. According to the World Health Organization, 1 billion people will ... is being given away to inform people about the significant adverse effect tobacco ... Organization,s World No Tobacco Day on May 31. Download the e-book and access ...
... is known about anticancer benefits of supplements, researchers caution , ... vitamins may do nothing to protect men against bladder cancer ... cancer. , In one study examining vitamin use, researchers analyzed ... took part in prostate screenings. , More than 60 ...
... of Alberta,s Faculty of Rehabilitation Medicine have made an ... for spinal-cord injuries. Karim Fouad and David Bennett have ... kick in after injury. To help understand the ... describe the neurons in the spinal cord that control ...
... More than ... International,s three-day eye camp beginning on June 6. Free cataract surgery with lens implant will ... several projects Touching Souls International is providing to the disadvantaged people of Bangladesh during ... ...
... feet first in shallow or unfamiliar waters, experts say , ... the age of 14 are hospitalized each year because of ... in a severe spinal cord injury, researchers say. , To ... to use caution near any body of water and to ...
... Founder ... Published in April 2010, the web store was created to promote healthy living to ... more. Visit the website’s new blog to read-up on product reviews, exercise tips and ... ...
Cached Medicine News:Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 2Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 3Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 4Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 5Health News:Celebrate The World Health Organization's World No Tobacco Day, and Get Free eBook - Protect Women from Tobacco Marketing and Smoke 6Health News:Vitamins Fail to Protect Men Against Bladder Cancer 2Health News:U of A discovery offers promising research for spinal-cord injury treatments 2Health News:Touching Souls International Giving Free Cataract Surgery and Eye Treatment in Bangladesh as Part of Ongoing Program June 6 2Health News:Touching Souls International Giving Free Cataract Surgery and Eye Treatment in Bangladesh as Part of Ongoing Program June 6 3Health News:Touching Souls International Giving Free Cataract Surgery and Eye Treatment in Bangladesh as Part of Ongoing Program June 6 4Health News:Dive Safely -- Or Risk Spinal Cord Damage 2Health News:DRW Weight Loss Debuts Website to Promote Healthy Living and Nutritional Aids 2
Clinical micro clamps by Acland. Black finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Micro emulsifying needles, 18G....
Micro 2000, micro scissors micro 2000 supercut....
Medicine Products: